Cargando…
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies
PURPOSE OF REVIEW: Patients diagnosed with CLL have an increased susceptibility to infections. Over the years, there has been a shift of the treatment arsenal to an increasing use of chemotherapy-free regimens, particularly small molecule inhibitors. These therapies have proven to be effective and h...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976213/ https://www.ncbi.nlm.nih.gov/pubmed/35366167 http://dx.doi.org/10.1007/s11912-022-01261-9 |